Allergy & Asthma Network Mothers of Asthmatics (AANMA) to Launch
the Great American Asthma Challenge
First-Ever National Grassroots Movement to End Asthma Deaths in the United States

WASHINGTON, DC, APRIL 28, 2010 – Every day 10 people die from asthma. Most healthcare providers agree that these deaths are preventable. Patient education, access to care and a healthy lifestyle are proven methods that lead to less severe asthma symptoms, fewer hospitalizations and emergency department visits, fewer missed days of school and work – and fewer deaths. Read the rest of this entry »

The Food and Drug Administration (FDA) has announced that seven more metered dose inhalers (MDIs) containing ozone-depleting propellants will be phased out. 

Four of the medications have already been discontinued: Tilade, Intal, Azmacort and Alupent; and two of the remaining three have a small market share: Aerobid and MaxAir. Combivent is used by patients with chronic obstructive pulmonary disease (COPD) and by some patients who have both COPD and asthma. 

The phase-out dates for each of these can be read here: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm208302.htm. [^] 

We expect that an Aerobid HFA replacement will be approved prior to its phase-out. We expect the same for Combivent. 

Visit our website, http://www.aanma.org, for more news and updates from AANMA. Thank you.

When 10-year-old Andye came to play with my daughter Alanna, I would always limit their time in the basement – not just because that’s where the TV was, but also because Andye was allergic to our cats. These calico beauties scattered their dander throughout the house, but I knew it collected heavily in the carpeted, windowless room downstairs. Read the rest of this entry »